Our Way Forward

Our Way Forward, created by TESARO, Inc. with input from the National Ovarian Cancer Coalition (NOCC) and the Ovarian Cancer Research Fund Alliance (OCRFA), is a call-to-action that encourages ovarian cancer patients, their loved ones and healthcare providers to rethink how they talk about advanced ovarian cancer and ways to partner together to navigate the physical and emotional challenges that the disease brings.

TESARO is committed to offering resources to educate, empower and support those affected by ovarian cancer.

Learn how Our Way Forward is redefining the ovarian cancer experience


About Ovarian Cancer

Ovarian cancer is the fifth leading cause of cancer death among women in the United States1. Oftentimes, ovarian cancer symptoms can be difficult to detect and unfortunately, recurrence is likely for advanced ovarian cancer patients.

Ovarian Cancer Statistics

  • Ribbon

    Ovarian cancer is

    the fifth leading

    cause of cancer death in American women.1

  • Map
    >22,000
    U.S Women

    are projected to be diagnosed with ovarian cancer annually - many of whom will be diagnosed with advanced disease.2

  • Women
    ~85%
    of Women

    with advanced ovarian cancer will recur after treatment.3

  • Patient

    With each subsequent treatment with a platinum-based chemotherapy regimen, progression-free survival generally gets shorter and response rates get progressively smaller.4

  • Woman
    >14K
    Women

    will die of ovarian cancer in 2017.5

  • prev
  • Slide
  • next
References
  • 1. Ovarian Cancer Statistics. Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/ovarian/statistics/. Accessed May 9, 2017.

  • 2. Cancer Facts and Figures. American Cancer Society.
    https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancerfacts-figures-2017.html.Accessed May 9, 2017.

  • 3. Lorusso D, Mancini M, Di Rocco R, Fontanelli R, Raspagliesi F. The role of secondary surgery in recurrent ovarian cancer [published online August

  • 5, 2012]. Int J Surg Oncol. 2012;2012:613980. doi:10.1155/2012/613980.

  • 4. Luvero D, Milani A, and Ledermann JA. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. Ther Adv Med Oncol.
    2014 Sep;6(5):229–239.

  • 5. A Snapshot of Ovarian Cancer. National Cancer Institute. https://www.cancer.gov/research/progress/snapshots/ovarian. Accessed May 9, 2017.

Spotlight

Kimberly’s Ovarian Cancer Tribe

Kimberly’s Ovarian Cancer Tribe

When Kim was first diagnosed with Stage IIc ovarian cancer, she hated telling other people she had cancer. But when she woke up from her first surgery to find herself surrounded by friends and family, she realized that letting others help her only made her stronger. Read more about her story and tips for creating a healthy support network.